Apolo V Acquisition Corp. acquires TelyRx
Apolo V Acquisition Corp. agreed to acquire TelyRx. Reported deal value: $40M. Status: Pending. Sector: Healthcare and pharmacy services. Target headquarters context: United States.
This page summarizes publicly available information about the transaction as of 2026-02-20. Figures and status may change as filings and press coverage update.
Apolo V Acquisition Corp . announces it has amended its business combination agreement with TelyRx , Inc. dated January 19, 2026 effected in connection with its previously announced proposed qualifying transaction and postponed its special meeting of shareholders , which had been scheduled to be held on February 19, 2026.Amended Business Combination Agreement The Company, TelyRx , TelyRx Finco Inc., 1001474388 Ontario Inc. and Apolo V MergerCo Inc. entered into an amending agreement dated February 19, 2026, amending the Business Combination Agreement
Deal timeline
This transaction is classified in Healthcare and pharmacy services with a reported deal value of $40M. Figures and status may change as sources update.